EYENOVIA INC

For the period ended Dec 31, 2023. Filed Mar 18, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Mar 18, 2024

HYPD$2.59+0.4%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Balance Sheets as of December 31, 2023 and 2022

Balance Sheets


· · December 31,
	2023		2022
Assets

Current Assets · · · ·
Cash and cash equivalents		$14,849,057		$22,863,520
Inventories		109,798		—
Deferred clinical supply costs		4,256,793		2,284,931
License fee and expense reimbursements receivable		123,833		1,183,786
Security deposits, current		1,506		119,550
Prepaid expenses and other current assets		1,365,731		1,190,719
Total Current Assets		20,706,718		27,642,506

Property and equipment, net		3,374,384		1,295,115
Security deposits, non-current		197,168		80,874
Intangible assets		2,122,945		—
Operating lease right-of-use asset		1,666,718		1,291,592
Equipment deposits		711,441		726,326
Total Assets		$28,779,374		$31,036,413

Liabilities and Stockholders’ Equity

Current Liabilities:
Accounts payable		$1,753,172		$1,428,283
Accrued compensation		1,658,613		1,747,191
Accrued expenses and other current liabilities		287,928		503,076
Operating lease liabilities - current portion		501,250		484,882
Notes payable - current portion, net of debt discount of $503,914 and $33,885 as of December 31, 2023 and 2022, respectively		5,329,419		174,448
Convertible notes payable - current portion, net of debt discount of $0 and $33,885 as of December 31, 2023 and 2022, respectively		—		174,448

Total Current Liabilities		9,530,382		4,512,328

Operating lease liabilities - non-current portion		1,292,667		907,644
Notes payable - non-current portion, net of debt discount of $448,367 and $813,229 as of December 31, 2023 and 2022, respectively		4,355,800		4,190,938
Convertible notes payable - non-current portion, net of debt discount of $398,569 and $813,229 as of December 31, 2023 and 2022, respectively		4,601,431		4,190,938

Total Liabilities		19,780,280		13,801,848

Commitments and contingencies (Note 9)

Stockholders' Equity:
Preferred stock, $0.0001 par value, 6,000,000 shares authorized;
0 shares issued and outstanding as of December 31, 2023 and 2022
Common stock, $0.0001 par value, 90,000,000 shares authorized; 45,553,026 and 36,668,980 shares issued and outstanding as of December 31, 2023 and 2022, respectively		4,555		3,667
Additional paid-in capital		154,486,098		135,461,361
Accumulated deficit		(145,491,559)		(118,230,463)

Total Stockholders’ Equity		8,999,094		17,234,565

Total Liabilities and Stockholders’ Equity		$28,779,374		$31,036,413

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.